查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945341

2026年全球免疫檢測市場報告

Immunoassay Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，免疫檢測市場經歷了顯著成長，預計將從2025年的373.2億美元成長到2026年的400.7億美元，複合年成長率（CAGR）為7.4%。過去幾年的成長可歸因於感染疾病和慢性病患病率的上升、臨床實驗室檢測量的增加、基於酶聯免疫吸附試驗（ELISA）的診斷方法的廣泛應用、藥物研發活動的擴展以及對疾病早期檢測需求的不斷成長。

預計未來幾年免疫檢測市場規模將穩定成長，到2030年將達到528.3億美元，複合年成長率（CAGR）為7.2%。預測期內的成長要素包括：對快速診斷的需求不斷成長、對個人化醫療的投資不斷增加、分散式檢查模式的擴展、數位化檢測工作流程的日益普及以及對伴隨診斷的日益重視。預測期內的主要趨勢包括：高靈敏度免疫檢測試劑盒的廣泛應用、自動化免疫檢測分析儀的日益普及、照護現場檢測（POC​​T）免疫檢測分析的需求不斷成長、多重免疫檢測平台的擴展以及與數據管理軟體的整合度不斷提高。

預計未來幾年，感染疾病和慢性病發病率的上升將推動免疫檢測市場的擴張。感染疾病和慢性病包括病原體引起的疾病以及需要持續監測、診斷和治療的長期健康問題。這些疾病發生率上升的主要原因是環境污染物暴露增加，這會損害免疫功能並增加患病風險。因此，感染疾病和慢性病的快速流行正在推動對免疫檢測的需求，促使醫療機構和診斷公司採用先進的檢測解決方案，以實現早期診斷、有效疾病監測和精準的臨床決策。例如，根據英國政府公共衛生機構－英國 Health Security Agency）發布的數據，截至2025年6月，英格蘭報告的曲狀桿菌感染疾病病例數從2023年的60,055例增加到2024年的70,352例，增加了10,297例，報告率從每10萬例人口104.1921.199例上升。因此，感染疾病和慢性病的日益增多推動了對基於免疫檢測的診斷解決方案的需求。

為了增強競爭優勢，免疫檢測市場的主要企業正致力於推出先進的免疫檢測分析儀。免疫檢測分析儀是一種實驗室系統，它透過免疫反應自動識別和測量蛋白質、荷爾蒙等生物物質。例如，2023年5月，專注於簡化、自動化和創新複雜生物醫學檢測的美國公司貝克曼庫爾特診斷（Beckman Coulter Diagnostics）推出了DxI 9000 Access免疫檢測分析儀。 DxI 9000 Access免疫檢測分析儀旨在滿足臨床檢查室對速度、可靠性、可重複性、品質和擴展檢測項目的需求。該系統展示了高靈敏度和臨床相關檢測方法的開發，有助於提高新藥療法的有效性，並有助於改善患者預後。它融合了先進的分析物處理和檢測技術、精密感測器、智慧演算法和遠端即時系統監控等創新技術，並且是目前唯一無需日常維護的免疫檢測儀系統。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球免疫檢測市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧和自主智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 高靈敏度免疫檢測試劑盒的應用日益廣泛
    • 自動化免疫檢測裝置的使用日益增多
    • 對照護現場免疫檢測檢測的需求日益成長
    • 擴展我們的多重免疫檢測平台
    • 增強資料管理軟體的整合

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 臨床檢查室
  • 研究機構和學術研究中心
  • 製藥和生物技術公司
  • 血庫

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球免疫檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球免疫檢測市場規模、對比及成長率分析
  • 全球免疫檢測市場表現：規模與成長，2020-2025年
  • 全球免疫檢測市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 試劑和試劑盒、分析設備或儀器、軟體和服務
  • 檢體
  • 血液、唾液、尿液和其他檢體
  • 透過使用
  • 治療藥物監測、腫瘤學、心臟病學、內分泌學、傳染病檢查、自體免疫疾病及其他應用
  • 最終用戶
  • 研究和學術實驗室、製藥和生物技術公司及合約研究組織 (CRO)、醫院和診所、臨床檢查室
  • 按類型細分：試劑和試劑盒
  • ELISA試劑盒、快速檢測套組、品管試劑及檢測方法開發用試劑
  • 按類型細分：分析儀器或設備
  • 自動化分析儀、就地檢驗設備、微孔盤讀數儀、發光儀
  • 按類型細分：軟體和服務
  • 資料管理軟體、分析軟體、支援與維護服務、諮詢服務

第10章 區域與國家分析

  • 全球免疫檢測市場：依地區、表現及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球免疫檢測市場：依國家、表現和預測分類，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 免疫檢測市場：競爭格局及市場佔有率（2024年）
  • 免疫檢測市場：公司估值矩陣
  • 免疫檢測市場：公司概況
    • Siemens Healthineers GmbH
    • bioMerieux
    • Abbott
    • Beckman Coulter Inc.
    • Quidel Corporation

第37章：其他領先和創新企業

  • Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年免疫檢測市場：提供新機會的國家
  • 2030年免疫檢測市場：充滿新機會的細分市場
  • 2030年免疫檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MIMMU02_G26Q1

Immunoassay is a bioanalytical test that utilizes the binding of antibodies to antigens to detect and quantify specific chemicals, playing a crucial role in the diagnosis of diseases. Information derived from immunoassay test results can be used to establish appropriate courses of therapy. This method relies on a competitive binding reaction between a limited number of receptors on a highly specific anti-analyte antibody, labeled versions of an analyte, and a significant portion of an unlabeled sample analyte.

The main types of immunoassay products include reagents and kits, analyzers or instruments, and software and services. Reagents are substances or products that accelerate a reaction and are commonly used in various tests. Immunoassay specimens include blood, saliva, urine, and others, and the technique is applied in therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases, and more. The end users of immunoassay products are diverse and include research and academic laboratories, home care settings, pharmaceutical and biotechnology companies, Contract Research Organizations (CROs), blood banks, hospitals and clinics, and clinical laboratories.

Tariffs are impacting the immunoassay market by increasing costs of imported reagents, antibodies, analyzers, electronic components, and laboratory consumables used across diagnostic and research applications. North America and Europe are most affected due to reliance on globally sourced assay materials and instrumentation, while Asia-Pacific faces cost pressures on export-oriented manufacturing of kits and analyzers. These tariffs are increasing testing costs and slowing procurement cycles for laboratories. However, they are also encouraging regional reagent manufacturing, local instrument assembly, and stronger domestic supply chains for immunoassay solutions.

The immunoassay market research report is one of a series of new reports from The Business Research Company that provides immunoassay market statistics, including immunoassay industry global market size, regional shares, competitors with a immunoassay market share, detailed immunoassay market segments, market trends and opportunities, and any further data you may need to thrive in the immunoassay industry. This immunoassay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunoassay market size has grown strongly in recent years. It will grow from $37.32 billion in 2025 to $40.07 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising prevalence of infectious and chronic diseases, increased clinical laboratory testing volumes, widespread adoption of elisa-based diagnostics, expansion of pharmaceutical research activities, growing demand for early disease detection.

The immunoassay market size is expected to see strong growth in the next few years. It will grow to $52.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostics, rising investments in personalized medicine, expansion of decentralized testing models, growing adoption of digital laboratory workflows, increasing focus on companion diagnostics. Major trends in the forecast period include increasing adoption of high-sensitivity immunoassay kits, rising use of automated immunoassay analyzers, growing demand for point-of-care immunoassay testing, expansion of multiplex immunoassay platforms, enhanced integration of data management software.

The rising incidence of infectious and chronic diseases is anticipated to support the expansion of the immunoassay market in the coming years. Infectious and chronic diseases encompass conditions caused by pathogenic organisms as well as long-term health disorders that require continuous monitoring, diagnosis, and treatment. The growing burden of these diseases is largely attributed to increased exposure to environmental pollutants, which compromise immune function and heighten vulnerability to illness. As a result, demand for immunoassays is increasing, as the accelerating prevalence of infectious and chronic conditions is encouraging healthcare providers and diagnostic companies to adopt advanced testing solutions that facilitate early diagnosis, effective disease surveillance, and precise clinical decision-making. For example, in June 2025, data from the UK Health Security Agency, a United Kingdom-based government public health body, indicated that reported Campylobacter cases in England rose from 60,055 in 2023 to 70,352 in 2024, representing an increase of 10,297 cases, or 17.1%, with the reporting rate climbing from 104.1 to 121.9 per 100,000 population. Consequently, the growing prevalence of infectious and chronic diseases is driving demand for immunoassay-based diagnostic solutions.

Major companies operating in the immunoassay market are focusing on the launch of advanced immunoassay analyzers to strengthen their competitive positioning. Immunoassay analyzers are laboratory systems that automate the identification and measurement of biological substances, such as proteins and hormones, through immunological reactions. For example, in May 2023, Beckman Coulter Diagnostics, a United States-based company specializing in simplifying, automating, and innovating complex biomedical testing, introduced the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer is designed to meet clinical laboratory requirements for high speed, reliability, reproducibility, quality, and expanded test menus. The system demonstrates the ability to develop highly sensitive and clinically meaningful assays, supporting the effectiveness of new pharmaceutical therapies and contributing to improved patient outcomes. It incorporates innovations such as advanced analyte processing and detection technologies, precision sensors, intelligent algorithms, and remote real-time system monitoring, and is distinguished as the only immunoassay analyzer system that requires no daily maintenance.

In January 2023, Heska Corporation, a US-based biotechnology firm, acquired MBio Diagnostics, Inc. for an undisclosed sum. This acquisition is intended to strengthen Heska Corporation's research, development, and manufacturing capabilities, primarily by incorporating LightDeck's innovative point-of-care technology. This integration will facilitate the launch of advanced diagnostic platforms, including a product for canine cancer screening. MBio Diagnostics, Inc. is a US-based company that specializes in immunoassays.

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMerieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immunoassay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunoassay market includes revenues earned by entities by supplying immunoassay kits, analyzers, and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunoassay Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immunoassay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunoassay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunoassay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Reagents And Kits; Analyzers Or Instruments; Software And Services
  • 2) By Specimen: Blood; Saliva; Urine; Other Specimens
  • 3) By Application: Therapeutic Drug Monitoring; Oncology; Cardiology; Endocrinology; Infectious Disease Testing; Autoimmune Diseases; Other Applications
  • 4) By End User: Research And Academic Laboratories; Pharmaceutical And Biotechnology Companies And CROs; Hospitals And Clinics; Clinical Laboratories
  • Subsegments:
  • 1) By Reagents And Kits: ELISA Kits; Rapid Test Kits; Control Reagents; Assay Development Reagents
  • 2) By Analyzers Or Instruments: Automated Analyzers; Point-Of-Care Testing Devices; Microplate Readers; Luminometers
  • 3) By Software And Services: Data Management Software; Analytical Software; Support And Maintenance Services; Consulting Services
  • Companies Mentioned: Siemens Healthineers GmbH; bioMerieux; Abbott; Beckman Coulter Inc.; Quidel Corporation; Ortho Clinical Diagnostics; Sysmex Corporation; Bio-Rad Laboratories Inc.; Becton Dickinson and Company; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; PerkinElmer Inc; WAK-Chemie Medical GmbH; J Mitra & Co Pvt Ltd; Kamiya Biomedical Company; Tosoh Corporation; Gyros Protein Technologies AB; BioCheck Inc.; Bio-Techn; DiaSorin S.p.A; Meso Scale Diagnostics LLC; QIAGE; Randox Laboratories Ltd.; Shenzhen Mindray Bio-Medical Electronics Co Ltd; Danaher Corporation; Hologic Inc.; Tecan Trading AG; Eurofins Scientific; Abcam plc; Enzo Biochem Inc.; Luminex Corporation; Quanterix Corporation; Roche Diagnostics; ZEUS Scientific Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Immunoassay Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Immunoassay Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Immunoassay Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Immunoassay Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Industry 4.0 And Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of High-Sensitivity Immunoassay Kits
    • 4.2.2 Rising Use Of Automated Immunoassay Analyzers
    • 4.2.3 Growing Demand For Point-Of-Care Immunoassay Testing
    • 4.2.4 Expansion Of Multiplex Immunoassay Platforms
    • 4.2.5 Enhanced Integration Of Data Management Software

5. Immunoassay Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Clinical Laboratories
  • 5.3 Research And Academic Laboratories
  • 5.4 Pharmaceutical And Biotechnology Companies
  • 5.5 Blood Banks

6. Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunoassay Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Immunoassay Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Immunoassay Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Immunoassay Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunoassay Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunoassay Market Segmentation

  • 9.1. Global Immunoassay Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Kits, Analyzers Or Instruments, Software And Services
  • 9.2. Global Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood, Saliva, Urine, Other Specimens
  • 9.3. Global Immunoassay Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
  • 9.4. Global Immunoassay Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories
  • 9.5. Global Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents
  • 9.6. Global Immunoassay Market, Sub-Segmentation Of Analyzers Or Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers
  • 9.7. Global Immunoassay Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

10. Immunoassay Market Regional And Country Analysis

  • 10.1. Global Immunoassay Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Immunoassay Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunoassay Market

  • 11.1. Asia-Pacific Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunoassay Market

  • 12.1. China Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunoassay Market

  • 13.1. India Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunoassay Market

  • 14.1. Japan Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunoassay Market

  • 15.1. Australia Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunoassay Market

  • 16.1. Indonesia Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunoassay Market

  • 17.1. South Korea Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunoassay Market

  • 18.1. Taiwan Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunoassay Market

  • 19.1. South East Asia Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunoassay Market

  • 20.1. Western Europe Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunoassay Market

  • 21.1. UK Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunoassay Market

  • 22.1. Germany Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunoassay Market

  • 23.1. France Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunoassay Market

  • 24.1. Italy Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunoassay Market

  • 25.1. Spain Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunoassay Market

  • 26.1. Eastern Europe Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunoassay Market

  • 27.1. Russia Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunoassay Market

  • 28.1. North America Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunoassay Market

  • 29.1. USA Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunoassay Market

  • 30.1. Canada Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunoassay Market

  • 31.1. South America Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunoassay Market

  • 32.1. Brazil Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunoassay Market

  • 33.1. Middle East Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunoassay Market

  • 34.1. Africa Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunoassay Market Regulatory and Investment Landscape

36. Immunoassay Market Competitive Landscape And Company Profiles

  • 36.1. Immunoassay Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Immunoassay Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Immunoassay Market Company Profiles
    • 36.3.1. Siemens Healthineers GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. bioMerieux Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Immunoassay Market Other Major And Innovative Companies

  • Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc.

38. Global Immunoassay Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immunoassay Market

40. Immunoassay Market High Potential Countries, Segments and Strategies

  • 40.1 Immunoassay Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Immunoassay Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Immunoassay Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer